Market Overview
The Paediatric Influenza Treatment Market is poised for significant growth, projected to increase from USD 593.2 million in 2024 to USD 811.83 million by 2032, reflecting a steady compound annual growth rate (CAGR) of 4% during the forecast period. This growth is driven by rising awareness about influenza-related complications in children, the increasing availability of pediatric-specific antiviral medications, and government-led vaccination and public health campaigns aimed at re